The Vectura team will be at the 35th Annual Drug Delivery to the Lungs conference (#DDL) in Edinburgh, 11-13 December. DDL is an event dedicated to pulmonary & nasal drug delivery, and developments in the field of inhalation therapy. These topics are close to our heart at Vectura, as they are the cornerstone of our business as a specialist inhalation CDMO. With 25+ years of experience in inhaled product development, we are committed to helping companies bring their inhaled medicines to market. If you would like an informal chat with a member of our expert team about how Vectura could support you, please contact us here: https://2ly.link/21RX7 #TeamVectura #PharmaExperts #InhaledTherapies
Vectura Group
制药业
Chippenham，Wiltshire 16,288 位关注者
We are a specialist inhalation CDMO helping you bring innovative inhaled medicines to market.
关于我们
Vectura is a provider of innovative inhaled drug delivery services that enable partners to bring their medicines to patients. With differentiated proprietary technology and pharmaceutical development expertise, Vectura is one of the few companies globally with the device, formulation and development capabilities to deliver a broad range of complex inhaled therapies. Vectura has thirteen key inhaled and eleven non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development. Our partners include Hikma, Novartis, Sandoz (a division of Novartis AG), Mundipharma, Kyorin, GSK, Bayer, Chiesi, Almirall, and Tianjin KingYork. For further information, please visit Vectura's website at www.vectura.com
- 网站
-
https://www.vectura.com/?utm_source=licp
Vectura Group的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Chippenham，Wiltshire
- 类型
- 私人持股
- 创立
- 1997
- 领域
- Pharmaceutical、Product development、Formulation、Drug delivery、Respiratory、Life Sciences、Medical Devices、Inhalers、Inhalation和CDMO
地点
Vectura Group员工
动态
-
There's still time to sign up for our next virtual event, "Biologic therapies: Charting the path from injectables to inhalation", taking place on Thursday 14th November. Register now: https://ow.ly/X7Po50TYqNr
Explore key properties for optimizing biologic dry powder formulations with Mireia Puig and Josh Newman in the live virtual event sponsored by Vectura Group. Register now: https://ow.ly/X7Po50TYqNr
-
-
Today is the final day of the BIO-Europe Autumn 2024 Conference! Our team is on-site and excited to meet you. Head to booth #189 to discuss your needs and hear more about how Vectura could support your product development needs. #BIOEurope
-
-
Explore key properties for optimizing biologic dry powder formulations with Mireia Puig and Josh Newman in the live virtual event sponsored by Vectura Group. Register now: https://ow.ly/X7Po50TYqNr
-
-
Our experts are delighted to be onsite at #BioEurope this week in Stockholm. To learn more about how Vectura supports companies in bringing their inhaled medicines to market visit us at booth #189. Alternatively, you can schedule a meeting with us at Partnering? System. https://lnkd.in/edKBRYf.
-
-
Just under a week to go until the BIO-Europe Autumn 2024 Conference! Vectura is a specialist inhalation CDMO. With 25+ years of experience in inhaled product development, we help companies bring their inhaled medicines to market. To learn more, visit our booth #189 or schedule a meeting with us in advance at Partnering? System. https://lnkd.in/edKBRYf. See you next week! #BIOEurope
-
-
Just under a week to go until the BIO-Europe Autumn 2024 Conference! Vectura is a specialist inhalation CDMO. With 25+ years of experience in inhaled product development, we help companies bring their inhaled medicines to market. To learn more, visit our booth #189 or schedule a meeting with us in advance at Partnering? System. https://lnkd.in/edKBRYf. See you next week! #BIOEurope
-
-
Our business development team is gearing up for the 30th annual BIO-Europe event in Stockholm Sweden! Join us at Booth #189 to learn more about our consultative, flexible and innovative inhalation toxicology assessments, drug-device combination development and clinical trial manufacturing services to help companies bring inhaled medicines to market. Drop a message to our experts tagged below or schedule a meeting with us in advance via Partnering? System (https://lnkd.in/ge93k9d) #BIOEurope (Mayet P., Andrew Plumridge, Kristian Nalson)
-
-
It’s happening! ? Vectura is proud to sponsor the?30th anniversary?of BIO-Europe Autumn 2024, Europe’s premier partnering event for the biotech, pharma, and finance industries! ? Join us in the vibrant city of?Stockholm, Sweden from November 4-6 at booth #189 and don’t miss the chance to connect with our team—schedule a meeting in advance via the Partnering? System (https://lnkd.in/eruKMrsd).
-
-
Day two at #CPHI2024! Our team of experts will be at booth #5D121 today and tomorrow, and they look forward to discussing your inhaled drug development needs. Vectura has a wealth of experience in inhaled therapies and device innovation. Come along and discuss how we can collaborate to achieve your goals in the respiratory space! #TeamVectura #PharmaExperts #InhaledTherapies
-